Drug resistance to HIV-1 Protease involves accumulation of multiple mutations
in the protein. Here we investigate the role of these mutations by using
molecular dynamics simulations which exploit the influence of the native-state
topology in the folding process. Our calculations show that sites contributing
to phenotypic resistance of FDA-approved drugs are among the most sensitive
positions for the stability of partially folded states and should play a
relevant role in the folding process. Furthermore, associations between amino
acid sites mutating under drug treatment are shown to be statistically
correlated. The striking correlation between clinical data and our calculations
suggest a novel approach to the design of drugs tailored to bind regions
crucial not only for protein function but also for folding.Comment: Revtex, 14 pages, 7 eps figures. Proteins, Structure Function and
Genetics, in press (2001